Sonoma pharmaceuticals announces u.s. launch of next generation advanced solution for pulse lavage irrigation at the symposium on advanced wound care fall conference

Boulder, co / accesswire / november 3, 2023 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced the u.s. launch of its intraoperative pulse lavage irrigation treatment, which can replace commonly used iv bags in a variety of surgical procedures. sonoma previously launched its pulse lavage irrigation treatment solution in europe and is introducing this product to the united states at the symposium on advanced wound care (sawc) fall conference in las vegas.
SNOA Ratings Summary
SNOA Quant Ranking